Integration of Receptor Tyrosine Kinases Determines Sensitivity to PI3Kα-selective Inhibitors in Breast Cancer

Yichao Xu(Shanghai Institute of Materia Medica), Linghua Meng(Shanghai Institute of Materia Medica)
Theranostics
January 1, 2017
Cited by 14


Related Papers